Angel investor · San Bruno, United States
Recorded investments.
A clearer sense of fit.
Find where your company fits, how rounds are assembled, and what happened after the first investment.
of dated first investments
were at Angel, Pre-Seed or Seed
One dot = one company at first recorded investment.
Written insights from the recorded portfolio, with the evidence linked below.
Susan Wojcicki has dated investments in 12 companies. 4 first entries were at Angel, Pre-Seed or Seed (33.3%). An early-stage founder can use the sector and stage filters to find comparable companies before approaching the investor.
Explore the evidence ↗1 first company relationships appear in the latest 24 months, compared with 5 in the preceding window. The latest recorded investment is 2024-08-22. This describes observed activity through 2026-05-22; it does not establish current availability.
Explore the evidence ↗3 of 11 companies with a full 24-month observation window raised another equity round. This investor backed 0 of those companies again within that window. The difference is a reason to research the wider syndicate, rather than assume the same investor will fund the next round.
Explore the evidence ↗HealthTech is the largest displayed sector by company count, appearing in 4 portfolio companies; sector tags overlap. 0 first entries carry a recorded lead flag and the median first-round syndicate includes 7.5 other named backers. Shared rounds are evidence of co-investment, not evidence of an introduction route.
Explore the evidence ↗Start with observed behavior.
Every rate has a defined denominator.
25th–75th percentile across 12 disclosed first rounds. Total round size; the investor’s own cheque is undisclosed.
Size your round ↗22 May 2024–22 May 2026, versus 5 in the preceding 24 months.
See the rhythm ↗3 of 11 companies with a full observation window. The next round can include any investor.
Follow the path ↗0 of the same 11 companies. Build a financing plan around the wider investor market.
Explore co-investors ↗Choose your sector and stage to find
companies he first backed in that space.
A match means a recorded investment in this category. It does not establish current interest or availability.
All sectors · All entry stages. Round amounts are total financing, in USD.
Provider of patient centered healthcare platform
$14M total first roundProvider of personalized thyroid care recommendations and treatment plans. It offers customized approaches based on individual symptoms and conditions, including hypothyroidism and Hashimoto's. Services encompass lab test analysis, medication adjustments, dietary advice, and holistic care guidance. The process involves an initial assessment to create a patient profile, followed by tailored recommendations and support from a care team to implement those recommendations using existing health insurance. The aim is to improve thyroid health and overall well-being.
$7.0M total first roundProvider of AI based custom solutions
$23M total first round| Sector | Seed | Series A | Series B | All stages |
|---|---|---|---|---|
| HealthTech | 4 | |||
| Artificial Intelligence | 2 | |||
| B2C E-Commerce | 2 | |||
| Clinical Data Repository | 1 | |||
| Healthcare IT | 1 | |||
| Disease Self Management | 1 | |||
| Symptom Checkers | 1 |
Use stage-specific financing ranges
to frame the size of your syndicate.
Logarithmic scale. A dot marks the median; the band spans the 25th–75th percentiles. These are entire rounds, not individual cheques.
A subsequent round and repeat backing
answer different fundraising questions.
Includes first investments on or before 22 May 2024. 1 newer companies and 0 undated histories are excluded. Follow-up stops at the dataset’s latest round on 22 May 2026. These observations do not measure returns or predict a company’s outcome.
| First stage | Eligible companies | Next round ≤24 mo | Same investor again ≤24 mo |
|---|---|---|---|
| Seed | 4 | 1 / 4 | 0 / 4 |
| Series A | 3 | 1 / 3 | 0 / 3 |
| Series B | 1 | 0 / 1 | 0 / 1 |
| Series C | 1 | 1 / 1 | 0 / 1 |
| Series D | 1 | 0 / 1 | 0 / 1 |
| Series E+ | 1 | 0 / 1 | 0 / 1 |
Separate first investments from later
rounds in companies already backed.
*2026 is partial, through 22 May. Bar height counts first investments + repeat rounds; earlier years are complete calendar periods in this dataset.
Frequent shared rounds suggest a place
to investigate sector and stage alignment.
2 shared rounds · 2 companies
Latest shared round Feb 20232 shared rounds · 2 companies
Latest shared round Jul 20231 shared rounds · 1 companies
Latest shared round Jun 20211 shared rounds · 1 companies
Latest shared round Feb 20231 shared rounds · 1 companies
Latest shared round Jul 2023Shared rounds establish recorded co-investment. They do not establish a personal connection, introduction route, or current willingness to invest.
First investment comes first.
Amounts refer to that entry round.
| Company | First backed | Entry stage | Total entry round | Same investor again? |
|---|---|---|---|---|
Solace Health ↗Redwood City | Aug 2024 | Series A | $14M | No later round recorded |
Eureka Health ↗Sacramento | Jul 2023 | Seed | $7.0M | No later round recorded |
Calypso ↗San Francisco | Jun 2023 | Series A | $23M | No later round recorded |
Moonhub ↗San Francisco | Feb 2023 | Series A | $9.4M | No later round recorded |
Tract ↗San Francisco | Sep 2022 | Seed | $7.0M | No later round recorded |
Tesorio ↗San Francisco | Jun 2022 | Series B | $17M | No later round recorded |
Apeel ↗Goleta | Aug 2021 | Series E+ | $250M | No later round recorded |
Getlabs ↗Santa Monica | Aug 2021 | Series A | $20M | No later round recorded |
Wheel the World ↗Berkeley | Aug 2021 | Seed | $2.0M | No later round recorded |
TMRW ↗New York City | Jun 2021 | Series C | $80M | No later round recorded |
Kindra ↗Santa Monica | Jun 2021 | Seed | $4.5M | No later round recorded |
ThirdLove ↗San Francisco | Feb 2019 | Series D | $55M | No later round recorded |
No companies match these filters. Try a broader sector or stage.
Kept in the 12-company portfolio; excluded from entry-timing calculations.
Search San Bruno, United States investor companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.